| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.096 | 30.711 | 32.193 | 32.211 | 27.545 | 24.305 |
| Total Income - EUR | - | - | - | - | 1.096 | 30.711 | 32.193 | 32.211 | 27.545 | 24.305 |
| Total Expenses - EUR | - | - | - | - | 0 | 15.267 | 14.178 | 25.115 | 11.964 | 15.316 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.096 | 15.444 | 18.015 | 7.096 | 15.581 | 8.989 |
| Net Profit/Loss - EUR | - | - | - | - | 1.062 | 14.733 | 17.542 | 6.775 | 15.306 | 7.688 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 2 | 1 |
Check the financial reports for the company - Virocex Consult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 1.138 | 15.030 | 18.871 | 12.276 | 17.216 | 17.964 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 148 | 2.636 | 4.983 | 10.607 | 15.769 | 13.499 |
| Cash | - | - | - | - | 990 | 12.394 | 13.888 | 1.669 | 1.447 | 4.464 |
| Shareholders Funds | - | - | - | - | 1.104 | 14.739 | 17.547 | 6.780 | 15.354 | 7.736 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 34 | 291 | 1.324 | 5.496 | 1.862 | 10.227 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6920 - 6920" | |||||||||
| CAEN Financial Year |
6920
|
|||||||||
Comments - Virocex Consult S.r.l.